On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, LabCorp announced that Covance, its drug development business, has deployed the Xcellerate COVID-19 solution…
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine has been selected to participate in a…
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
On Jun. 25, 2020, LabCorp announced the launch of a new test that can be used to assess…
On Jun. 24, 2020, RedHill Biopharma announced that results from the treatment of the first severe COVID-19 patients…
On Jun. 24, 2020, Howard Hughes Medical Institute (HHMI) investigators reported that data from COVID-19 cases around the…
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
On Jun. 19, 2020, The COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….